Pengaruh Batas Insisi, Indeks Mitosis, Dan Tumor Nekrosis Terhadap Angka Rekurensi Tumor Phyllodes

Dian Yuliartha Lestari(1*), Gita Sekar Prihanti(2)

(1) FK UMMalang, Malang
(2) FK UMMalang, Malang
(*) Corresponding Author


Background: Phyllodes tumor is one neoplasms fibroepitelial rare, approximately less than 1 % of all breast neoplasms. Determination of prognosis of phyllodes tumors based on histopathologic classification is difficult to implement. To evaluate the phyllodes tumor, an important marker for prognostic factors, mainly based on the criteria of phyllodes tumor itself (such as mitotic index, limits the incision).Purpose: To determine the effect limits the incision, mitotic index and tumor necrosis against phyllodes tumor recurrence rate.Methods: An observational analytic study of the period 2009-2011 and followed through 2014. To determine the effect on recurrence rate limit incision Mann Whitney test , to determine the effect on the mitotic index recurrence rate testunpaired t -test , and to determine the effect of the tumor necrosis recurrence rate chi square test .Result: Obtained 16 samples that met the inclusion criteria with 10 samples and 6 samples did not relapse relapse. There were no influences between adjacent incisions (p = 0.05) , mitotic index (p = 0.06) , and tumor necrosis (p = 0.152) for phyllodes tumor recurrence rateConclusion: There were no influences between adjacent incision, mitotic index , and tumor necrosis against phyllodes tumor recurrence rate


limits the incision; mitotic index; tumor nekrosis; phyllodestumor; recurrence rate

Full Text:



Parkers, SJ; Harries, SA. Phyllodes Tumor. PostgradMed I. 2001. 77: 428-435

Tse, Gary MK; Lui, Philip CW; Vong, Joaquim SL;Lau, Kin-Mang; Putti, Thomas C; Karim, Rooshdiya;Scolyer, Richard A; Lee, C-Sonn; Yu, Alex MC; Ng,David CH; Tse, Agnes KY; Tan, Puay-Hoon.Increased epidermal growth factor receptor (EGFR)expression in malignant mammary phyllodes tumors.Breast Cancer Res Treat. 2009. 114: 441-448

Kuijper, Arno. Pathogenesis and Progression ofFibroepithelial Breast Tumours. 2006. UniversiteitUtrecht

Rosen, Paul Peter. Rosen’s Breast Pathology, 3rd Edition. 2009. Lippincott Williams and Willkins. New York

Vol. 1 No. 2 Juli 2015144 Dian Y. L, et al.

Jacklin, RK; Ridgway, PF; Ziprin, P; Healy, V;Hadjilminos, D; Darzi, A. Optimising preoperativediagnosis in phyllodes tumour of the breast. J ClinPathol. 2006. 59(5): 454-459

Bandyopadyay, Ranjana; Nag, Dipawita; Mundal,Santhos Kumar; Mukhopadyay, Subhalaksmi; Roy,Sumit; Sinha, Swapankumar. Distinction ofphyllodes tumor from fibroadenoma: Cytologist perspective. Journal of Cytology. 2010. Vol 27.Issue 2: 59-62

Esposito, Nicole Nicosia MD; Mohan, Deepak MD; Brufsky, Adam MD. PhD; Lin, Yan. PhD; Kapali,Malathy, MD; Dabbs, David J. MD. Phyllodes Tumor. A Clinicopathologic and Immunohis-tochemical Study of 30 Cases. Arch Pathol LabMed. 2006. 130: 1516-1521

Kleer, Celina G; Giordano, Thomas J; Braun,Thomas; Oberman, Harold A. Pathologic, Immunohistochemical, and Molecular Features of Benign and Malignant Phyllodes Tumors of the Breast. Mod Pathol. 2001. 14(3): 1985-190

Tan, Puay-Hoon; Jayabaskar, Thiyagarajan; Chuah,Khoon-Leong; Lee, Hwie-Yee; Tan, Yen; Hilmy,Maryam; Huang, Huunh; Salvarajan,

Article Metrics

Abstract view : 567 times
PDF - 143 times



  • There are currently no refbacks.

Indexed by




Creative Commons License

MAGNA MEDIKA by APKKM is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.